The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study, Lancet, vol.388, pp.30579-30586, 2013. ,
, Global health sector strategy on viral hepatitis, 2016.
, Switzerland: Geneva, WHO. Global hepatitis report, 2017.
, WHO. Guidelines on hepatitis B and C testing, 2017.
Validation of rapid point-of-care (POC) tests for the detection of hepatitis B surface antigen (HBsAg) in field and laboratory settings in The Gambia, West Africa, J Clin Microbiol, vol.53, pp.1156-1163, 2015. ,
Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study, Lancet Glob Heal, vol.4, pp.30130-30139, 2016. ,
Costeffectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis, Lancet Glob Heal, vol.4, pp.30101-30103, 2016. ,
, European Association for the Study of the Liver. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection, J Hepatol, vol.57, pp.167-185, 2012.
AASLD guidelines for treatment of chronic hepatitis B, Hepatology, vol.63, pp.261-283, 2016. ,
AsianPacific clinical practice guidelines on the management of hepatitis B: a 2015 update, Hepatol Int, vol.10, pp.1-98, 2016. ,
Reducing the neglected burden of viral hepatitis in Africa: strategies for a global approach, J Hepatol, vol.62, pp.469-476, 2015. ,
Prevalence of chronic hepatitis B virus infection and infrastructure for its diagnosis in Madagascar: implication for the WHO's elimination strategy, BMC Public Health, vol.17, p.636, 2017. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01653384
, Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection, 2015.
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACHB): development and validation of a predictive score, Lancet Oncol, vol.12, issue.11, pp.70077-70085, 2011. ,
Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia, Gut, vol.65, pp.2007-2016, 2016. ,
Food intake increases liver stiffness measurements and hampers reliable values in patients with chronic hepatitis B and healthy controls: the PROLIFICA experience in The Gambia, Aliment Pharmacol Ther, vol.39, pp.188-196, 2014. ,
Implementation of an in-house quantitative real-time polymerase chain reaction method for Hepatitis B virus quantification in West African countries, J Viral Hepat, vol.23, pp.897-904, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01792611
The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa, Gut, vol.65, pp.1369-1376, 2016. ,
Determination of reliability criteria for liver stiffness evaluation by transient elastography, Hepatology, vol.57, pp.1182-1191, 2013. ,
Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers, J Clin Oncol, vol.28, pp.1660-1665, 2010. ,
Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection, J Clin Oncol, vol.28, pp.2437-2444, 2010. ,
Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B, J Hepatol, vol.60, pp.339-345, 2014. ,
Evaluation of data quality at the Gambia National Cancer Registry, Int J Cancer, vol.132, pp.658-665, 2013. ,
Liver stiffness measurement and biochemical markers in Senegalese chronic hepatitis B patients with normal ALT and high viral load, PLoS One, vol.6, 2011. ,
Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)infected patients in Burkina Faso, Am J Trop Med Hyg, vol.82, pp.454-458, 2010. ,
Presentation of multivariate data for clinical use: The Framingham Study risk score functions, Stat Med, vol.23, pp.1631-1660, 2004. ,
Prognosis and prognostic research: validating a prognostic model, BMJ, vol.338, p.605, 2009. ,
Bias, prevalence and kappa, J Clin Epidemiol, vol.46, pp.423-429, 1993. ,
STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies, BMJ, vol.351, 2015. ,
Hepatitis B treatment eligibility in West Africa: uncertainties and need for prospective cohort studies, Liver Int, vol.37, pp.1116-1121, 2017. ,
Early experiences from one of the first treatment programs for chronic hepatitis B in sub-Saharan Africa, BMC Infect Dis, vol.17, p.438, 2017. ,
Natural history and clinical management of chronic hepatitis B virus infection in children, Hepatol Int, vol.2, pp.28-36, 2008. ,
Geographic variation in viral load among hepatitis B carriers with differing risks of hepatocellular carcinoma, Cancer Epidemiol Biomarkers Prev, vol.7, pp.559-565, 1998. ,
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level, JAMA, vol.295, pp.65-73, 2006. ,
Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa, J Viral Hepat, vol.17, pp.115-122, 2010. ,
Health Organization model list of essential in vitro diagnostics, 2018. ,
Evaluation of a new rapid test for the combined detection of hepatitis B virus surface antigen and hepatitis B virus e antigen, J Clin Microbiol, vol.40, pp.4603-4606, 2002. ,
Performance of an optimized paper-based test for rapid visual measurement of alanine aminotransferase (ALT) in fingerstick and venipuncture samples, PLoS One, vol.10, pp.1-15, 2015. ,
Requirements for global elimination of hepatitis B: A modelling study, Lancet Infect Dis, vol.16, issue.16, pp.30204-30207, 2016. ,
Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States, Hepatology, vol.48, pp.1070-1078, 2008. ,